Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease

医学 安慰剂 内科学 随机化 胃肠病学 胆固醇 临床终点 随机对照试验 脂蛋白 家族性高胆固醇血症 血脂谱 内分泌学 病理 替代医学
作者
Anne C. Goldberg,Lawrence A. Leiter,Erik S.G. Stroes,Seth J. Baum,Jeffrey C. Hanselman,LeAnne T. Bloedon,Narendra D. Lalwani,Pragna Patel,Xin Zhao,P. Barton Duell
出处
期刊:JAMA [American Medical Association]
卷期号:322 (18): 1780-1780 被引量:471
标识
DOI:10.1001/jama.2019.16585
摘要

Importance: Additional treatment options are needed for patients who do not achieve sufficient reduction in low-density lipoprotein cholesterol (LDL-C) level with available lipid-lowering therapies. Objective: To assess the efficacy of bempedoic acid vs placebo in patients at high cardiovascular risk receiving maximally tolerated lipid-lowering therapy. Design, Setting, and Participants: Phase 3, randomized, double-blind, placebo-controlled clinical trial conducted at 91 clinical sites in North America and Europe from November 2016 to September 2018, with a final date of follow-up of September 22, 2018. A total of 779 patients with atherosclerotic cardiovascular disease, heterozygous familial hypercholesterolemia, or both met randomization criteria, which included LDL-C level 70 mg/dL (1.8 mmol/L) or greater while receiving maximally tolerated lipid-lowering therapy. Interventions: Patients were randomized 2:1 to treatment with bempedoic acid (180 mg) (n = 522) or placebo (n = 257) once daily for 52 weeks. Main Outcomes and Measures: The primary end point was percent change from baseline in LDL-C level at week 12. Secondary measures included changes in levels of lipids, lipoproteins, and biomarkers. Results: Among 779 randomized patients (mean age, 64.3 years; 283 women [36.3%]), 740 (95.0%) completed the trial. At baseline, mean LDL-C level was 120.4 (SD, 37.9) mg/dL. Bempedoic acid lowered LDL-C levels significantly more than placebo at week 12 (-15.1% vs 2.4%, respectively; difference, -17.4% [95% CI, -21.0% to -13.9%]; P < .001). Significant reductions with bempedoic acid vs placebo were observed at week 12 for non-high-density lipoprotein cholesterol (-10.8% vs 2.3%; difference, -13.0% [95% CI, -16.3% to -9.8%]; P < .001), total cholesterol (-9.9% vs 1.3%; difference, -11.2% [95% CI, -13.6% to -8.8%]; P < .001), apolipoprotein B (-9.3% vs 3.7%; difference, -13.0% [95% CI, -16.1% to -9.9%]; P < .001), and high-sensitivity C-reactive protein (median, -18.7% vs -9.4%; difference, -8.7% [asymptotic confidence limits, -17.2% to -0.4%]; P = .04). Common adverse events included nasopharyngitis (5.2% vs 5.1% with bempedoic acid and placebo, respectively), urinary tract infection (5.0% vs 1.9%), and hyperuricemia (4.2% vs 1.9%). Conclusions and Relevance: Among patients at high risk for cardiovascular disease receiving maximally tolerated statins, the addition of bempedoic acid compared with placebo resulted in a significant lowering of LDL-C level over 12 weeks. Further research is needed to assess the durability and clinical effect as well as long-term safety. Trial Registration: ClinicalTrials.gov Identifier: NCT02991118.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sxnyyy发布了新的文献求助10
刚刚
852的应助被勤恳的饭饭采纳,获得10
刚刚
Lu发布了新的文献求助10
1秒前
栗栗子完成签到,获得积分10
1秒前
1秒前
pyj完成签到,获得积分10
1秒前
Mahc完成签到,获得积分10
3秒前
3秒前
我是老大的应助被端庄威采纳,获得10
3秒前
Orange的应助被热爱科研的小孩采纳,获得10
4秒前
FashionBoy的应助被阿盛采纳,获得10
4秒前
5秒前
nini完成签到,获得积分10
5秒前
bkagyin的应助被简单的飞凤采纳,获得10
6秒前
AnnChen发布了新的文献求助10
6秒前
华仔的应助被LL采纳,获得10
7秒前
zfr完成签到 ,获得积分10
7秒前
Ma发布了新的文献求助10
7秒前
yy发布了新的文献求助30
7秒前
完美世界的应助被exile采纳,获得10
8秒前
嘻嘻哈哈发布了新的文献求助210
8秒前
zzk发布了新的文献求助10
8秒前
11发布了新的文献求助10
9秒前
彭于晏的应助被saiki采纳,获得10
9秒前
10秒前
10秒前
踏实的曲奇完成签到,获得积分10
10秒前
11秒前
mtt完成签到,获得积分10
11秒前
abandon发布了新的文献求助10
12秒前
多啦a萌完成签到,获得积分20
13秒前
13秒前
wjsbhsn完成签到,获得积分20
14秒前
lisa完成签到,获得积分10
14秒前
玫瑰发布了新的文献求助20
14秒前
多啦a萌发布了新的文献求助10
15秒前
这里有妖气完成签到,获得积分10
15秒前
风飒飒完成签到 ,获得积分10
16秒前
张婷完成签到,获得积分10
16秒前
乎乎发布了新的文献求助30
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148